HHW-28159-88882
3 vaccinations
1 coded response
22 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 716 / AR
- Registered
- 2020-12-16
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- N/A
Timeline
-
2020-12-16
Registered in v-safe
-
2020-12-16
Dose 1 — Pfizer-BioNTech
- 2020-12-16
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-26
- 2020-12-30
-
2021-01-05
Dose 2 — Pfizer-BioNTech
-
2021-01-06
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: FairFree text: Soreness injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-11
- 2021-01-20
- 2021-01-26
- 2021-02-04
- 2021-02-11
- 2021-02-16
- 2021-04-09
-
2021-10-01
Dose 3 — Pfizer-BioNTech
- 2021-10-03
- 2021-10-07
- 2021-11-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Soreness injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release